STDY - sold @4.1-4.4 in the last few days for over 60% gain.
They have a catalyst in April that if successful, can move the stock higher, but the stock is overbought and what i made is good enough for me.
>>Obtaining a favorable ruling in our Inter Partes Review (IPR) challenge against U.S. Patent No. 8,497,393 (the '393 patent) owned by United Therapeutics Corporation in early Q2.<<
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.